|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print March 28, 2002
Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00545.2001
Submitted on June 25, 2001
Accepted on March 26, 2002
1 Division of Endocrinology and Metabolism, Department of Medicine, Jichi Medical School, Minamikawachi, Tochigi, Japan
2 Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical School, Minamikawachi, Tochigi, Japan
* To whom correspondence should be addressed. E-mail: fujitaem{at}jichi.ac.jp.
E2F is a family of transcriptional factors that control G1/S transition. We investigated how E2F family participates in the biological responses of vascular smooth muscle cells (VSMC) to vasoconstrictive hormones in comparison with fetal bovine serum (FBS). FBS induced up-regulation of E2F-1 and E2F-5 at both mRNA and protein levels, and slightly reduced E2F-3 protein. Angiotensin II (ANG II) and arginine vasopressin (AVP) increased E2F-3 protein, but not E2F-1 and E2F-5, without up-regulating its mRNA level. FBS transactivated E2F-1 gene through the induction of free E2F-1 binding onto its promoter, whereas ANG II-induced binding of E2F-3 did not result in activation of the E2F-1 promoter. These changes are responsible for hypertrophic or hyperplastic response of VSMC to different growth factors or stimulants. In contrast, both FBS and vasoconstrictive hormones drove transcription of the cdc6 gene by down-regulating p130 and recruiting free E2F-3 in the latter, which underlies the progression of VSMC into S phase.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |